Shasun Pharmaceuticals has informed the BSE that the company’s board will meet on June 8 to consider conversion of 71 lakh convertible warrants issued to Sequent Scientific, Mumbai, on preferential basis, to equity shares. In view of this, the trading window for equity shares will be closed for directors and designated employees of the company from Tuesday to June 10.